Artificial intelligence has been making headway in healthcare. One country that has embraced the technology faster than any other is China, especially in relation to lung cancer detection methods.
One reason for the focus on lung cancer is because China has one of the highest lung cancer rates in the world. According to Time Magazine, Chines medics predict that over 800,000 annual diagnoses and 700,000 annual deaths can be expected by 2020.
An estimated 300 million Chinese people are smokers. At the hospital, radiologists have been operating an artificial intelligence technology produced by Infervison. The technology aims to improve medical diagnosis from the processing of computed tomography scans and X-rays.
Again according to Forbes, the technology can identify suspicious lesions and nodules in lung cancer patients. Infervison works with a number of other major medical technology firms, such as GE Healthcare, Cisco, and Nvidia. The system is being tested out in over twenty tertiary grade A hospitals in China
